Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Biotechnology

Health & Wellness

Geron

Geron's headquarters in Menlo Park, CA, United States

Tj McLaughlin

Michelle Robertson

Jr Raelin

Stewart Hackney

Melissa A. Kelly Behrs

Andrew J. Grethlein

Peter A. Avalos

Joe Denton

Rachel Williams

Ying Wan

Mary Foster

Michael Yamada

Patrick Murphy

Shannon Odam

Alan Chan

Katherine Harmon

Kellie Winemiller Rn Bsn

Jimmy Evans

Shannon Maryman

Dawn C. Bir

Elizabeth G. O'Farrell

Gaurav Aggarwal

John F. McDonald

V. Bryan Lawlis

Susan M. Molineaux

Robert J. Spiegel

The Directors team at Geron plays a critical role in steering the company's strategic initiatives and overall corporate governance. This team is responsible for overseeing different facets of the business including finance, IT, patient marketing, scientific communications, quality assurance, channel marketing, commercial operations, and global pricing. Collectively, these leaders work together to ensure that Geron's mission of developing and commercializing innovative treatments for hematologic myeloid malignancies is successfully realized.

Directors

The Clinical Operations Team at Geron is responsible for overseeing and managing the company's clinical trials, ensuring they are conducted efficiently, compliantly, and within established timelines. This team works collaboratively to plan, execute, and monitor clinical studies, support regulatory submissions, maintain quality assurance, and provide critical scientific and medical insights to advance the development of Geron's lead telomerase inhibitor, imetelstat, for the treatment of hematologic myeloid malignancies.

Clinical Operations Team

The Medical and Clinical Teams at Geron are responsible for the development, clinical evaluation, and potential commercialization of imetelstat, a telomerase inhibitor targeting hematologic myeloid malignancies. Their duties include designing and overseeing clinical trials, analyzing clinical data, ensuring regulatory compliance, developing scientific communications, managing patient services and medical affairs, and strategizing real-world evidence and field medical operations to support the drug's pathway from trials to market.

Medical and Clinical Teams

The Leadership Team at Geron is responsible for guiding the strategic direction of the company, overseeing the development and commercialization of imetelstat, and ensuring effective operations across all divisions. Comprised of experienced executives in business, medicine, and operations, this team collaborates to advance Geron's mission in hematologic malignancies while fostering partnerships and driving innovation in clinical research.

Leadership Team

The Business Operations Team at Geron is responsible for ensuring the company's operational efficiency and strategic effectiveness. This involves overseeing business systems management, conducting market and supply chain analysis, managing office and purchasing processes, and providing critical market research and financial reporting to support the development and potential commercialization of imetelstat.

Business Operations Team

The Human Resources Team at Geron oversees talent acquisition, employee relations, payroll administration, and HR strategy implementation. They ensure the company attracts, retains, and develops top talent, while fostering a positive and productive workplace environment to support the company's biopharmaceutical initiatives.

Human Resources Team

Geron

Org chart

Board & advisors

Teams

Directors

Clinical Operations Team

Medical and Clinical Teams

Leadership Team

Business Operations Team

Human Resources Team

Offices

Geron

Org chart

Board & advisors

Teams

Directors

Clinical Operations Team

Medical and Clinical Teams

Leadership Team

Business Operations Team

Human Resources Team

Offices

Related companies